Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03752619 · ClinicalTrials.gov registry record · NA

Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)

A NA study of Shoulder Pain and Shoulder Impingement Syndrome, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
116
Enrollment target
2
Study locations

NCT03752619: Completed NA study of Shoulder Pain and Shoulder Impingement Syndrome, sponsored by MetroHealth Medical Center.

NCT03752619 is a NA study of Shoulder Pain and Shoulder Impingement Syndrome that has completed, run by MetroHealth Medical Center. The registered enrollment target is 116 participants, above the 97-participant average among 27 other Shoulder Pain trials with a reported enrollment target (20% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03752619, a NA study of Shoulder Pain and Shoulder Impingement Syndrome, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target
2
Study locations

Study Summary

Shoulder pain accounts for 16% of all musculoskeletal complaints in the healthy adult population. Subacromial impingement syndrome (SIS) is the most common cause of shoulder pain. Many patients with chronic pain from subacromial impingement syndrome (SIS) will fail treatment efforts and have longstanding pain. This project will evaluate the efficacy of a novel approach to treatment, percutaneous peripheral nerve stimulation, for participants with chronic shoulder pain due to subacromial impingement syndrome (SIS).

Primary Outcome

The Brief Pain Inventory (BPI)has excellent psychometrics. The developers of the Brief Pain Inventory (BPI) recommend Brief Pain Inventory (BPI )3, the "pain worst" rating, as the primary response metric. The question asks participants to rate their worst pain in the prior 24-hours OR prior 7-day on a 0 to 10 Numerical Rating Scale (NRS), where "0" indicates "No pain" and "10" indicates "Pain as bad as you can imagine."

Interventions

  • OTHER Physical Therapy
  • DEVICE Contracting Producing Peripheral Nerve Stimulation
  • DEVICE Non Contracting Producing Peripheral Nerve Stimulation

Study Locations (2)

Ohio

  • MetroHealth Medical Center - Cleveland

Texas

  • Univerity of Texas Southwestern - Dallas

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2019-03-01
Est. Completion 2024-06-21
Phase NA
MetroHealth Medical Center

76 total trials

What the finished NCT03752619 record still lists

NCT03752619 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, above the 97-participant average among 27 other Shoulder Pain trials with a reported enrollment target (20% higher).

The record links to 5 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 3 interventions - of which Physical Therapy is the first listed.

NCT03752619 reports a single indexed study location in Ohio, Texas.

Frequently Asked Questions

What is clinical trial NCT03752619 about?

NCT03752619 is a clinical study titled "Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)". Shoulder pain accounts for 16% of all musculoskeletal complaints in the healthy adult population. Subacromial impingement syndrome (SIS) is the most common cause of shoulder pain. Many patients with chronic pain from subacromial impingement syndrome (SIS) will fail treatment efforts and have longsta...

What is the current status of trial NCT03752619?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2019-03-01. Estimated completion is 2024-06-21.

What conditions does trial NCT03752619 study?

This clinical trial studies the following conditions: Shoulder Pain, Shoulder Impingement Syndrome, Pain, Shoulder, Shoulder Tendinitis, Shoulder Bursitis.

What interventions are being tested in trial NCT03752619?

The interventions under investigation include: Physical Therapy (OTHER), Contracting Producing Peripheral Nerve Stimulation (DEVICE), Non Contracting Producing Peripheral Nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03752619?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03752619 being conducted?

This trial has 2 study locations across Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03752619's enrollment target sits among peer trials

116 7th of 27 higher than 21 of 27 other Shoulder Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03752619, the US trial registry maintained by the National Library of Medicine. NCT03752619 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.